International audience
-
November 22, 2010 (v1)Journal articleUploaded on: December 4, 2022
-
December 2012 (v1)Journal articleSerum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.
Regarding the frequency of muscular complains with the use of tyrosine kinase inhibitors (TKIs), we hypothesize that creatine kinase (CK) elevation may be more frequent than usually reported. We conducted a prospective study on patients treated with TKIs for solid tumors, to assess the incidence of CK increase on treatment. Most of the patients...
Uploaded on: October 11, 2023 -
December 2012 (v1)Journal articleSerum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.
Regarding the frequency of muscular complains with the use of tyrosine kinase inhibitors (TKIs), we hypothesize that creatine kinase (CK) elevation may be more frequent than usually reported. We conducted a prospective study on patients treated with TKIs for solid tumors, to assess the incidence of CK increase on treatment. Most of the patients...
Uploaded on: December 4, 2022 -
September 1, 2015 (v1)Journal article
Purpose The aim of this randomized, phase II trial was to explore the activity and safety of adding bevacizumab to paclitaxel once per week in treatment of angiosarcomas (AS). Methods Patients were treated with paclitaxel alone (90 mg/m 2 per week for six cycles of 28 days each; arm A) or with paclitaxel combined with bevacizumab (10 mg/kg once...
Uploaded on: December 3, 2022